Role of transtelephonic electrocardiographic monitoring in detecting short-term arrhythmia recurrences after radiofrequency ablation in patients with atrial fibrillation

Journal of the American College of Cardiology

Volumn 45, Issue 6, 2005, Pages 873-876

  Senatore, Gaetano ^a,d   Stabile, Giuseppe ^b   Bertaglia, Emanuele ^c   Donnici, Giovanni ^a   De Simone, Antonio ^b   Zoppo, Franco ^c   Turco, Pietro ^b   Pascotto, Pietro ^c   Fazzari, Massimo ^a  

^a Ospedale Civile di Cirie TO   (Italy)

^b Casa di Cura San Michele   (Italy)

^c Ospedale Civile di Mirano   (Italy)

^d Divisione di Cardiologia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; FLECAINIDE; WARFARIN;

ADULT; AGED; ARTICLE; CATHETER ABLATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAPHY MONITORING; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HOLTER MONITORING; HUMAN; INCIDENCE; LUNG VEIN; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RECORDING; RECURRENT DISEASE; REFRACTORY PERIOD; RELAPSE; STANDARD; SYMPTOM; TELEPHONE; TRICUSPID VALVE;

EID: 14844303326     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.11.050     Document Type: Article

References (18)

1. E.S. Kaufman, A.L. Waldo The impact of asymptomatic atrial fibrillation J Am Coll Cardiol 43 2004 53 54
2. A.K. Bhandari, J.L. Anderson, E.M. Gilbert, the Flecainide Supraventricular Tachycardia Study Group Correlation of symptoms with the occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study Am Heart J 124 1992 381 386
3. R.L. Page, T.W. Tilsch, S.L. Connolly, for the Azimilide Supraventricular Arrhythmia Program (ASAP) Investigators Asymptomatic or 'silent' atrial fibrillation: frequency in untreated patients and patients receiving azimilide Circulation 107 2003 1141 1145
4. R.L. Page Beta-blockers for atrial fibrillation: must we consider asymptomatic arrhythmias? J Am Coll Cardiol 36 2000 147 150
5. G. Stabile, E. Bertaglia, G. Senatore Feasibility of pulmonary vein ostia radiofrequency ablation in patients with atrial fibrillation: a multicenter study (CACAF Pilot Study) Pacing Clin Electrophysiol 26 2003 284 287
6. S.H. Lee, S.A. Chen, C.T. Tai Comparison of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular modification in patients with medically refractory atrial fibrillation J Am Coll Cardiol 31 1998 637 644
7. S. Levy, M. Maarek, P. Coumel Characterization of different subsets of atrial fibrillation in general practice in France: the ALFA study Circulation 99 1999 3028 3035
8. K.H. Humphries, C.R. Kerr, S. Connolly New-onset altrial fibrillation: sex difference in presentation, treatment, and outcome Circulation 103 2001 2365 2370
9. S. Kinlay, J.W. Leitch, A. Neil, B.L. Chapman, D.B. Hardy, P.J. Fletcher Cardiac event recorders yield more diagnoses and are more cost-effective than 48-hour Holter monitoring in patients with palpitations Ann Intern Med 124 1996 16 20
10. F. Roche, J.M. Gaspoz, A. Da Costa Frequent and prolonged asymptomatic episodes of paroxysmal atrial fibrillation revealed by automatic long-term event recorders in patients with a negative 24-hour Holter Pacing Clin Electrophysiol 25 2002 1587 1593
11. C.W. Israel, G. Gronefeld, J.R. Ehrlich, Y.G. Li, S.H. Hohnloser Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care J Am Coll Cardiol 43 2004 47 52
12. C. Pappone, V. Santinelli, F. Manguso Pulmonary vein denervation enhances long term benefit after circumferential ablation for paroxysmal atrial fibrillation Circulation 109 2004 327 334
13. H. Oral, S. Veerareddy, E. Good Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation J Cardiovasc Electrophysiol 15 2004 920 924
14. M.H. Hsieh, C.T. Tai, C.F. Tsai Clinical outcome of very late recurrence of atrial fibrillation after catheter ablation of paroxysmal atrial fibrillation J Cardiovasc Electrophysiol 14 2003 598 601
15. H. Kottkamp, H. Tanner, R. Kobza Time course of quantitative analysis of atrial fibrillation episode number and duration after circular plus linear left atrial lesions J Am Coll Cardiol 44 2004 869 877
16. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation N Engl J Med 84 1991 527 539
17. M.D. Ezekowitz, S.L. Bridgers, K.E. James, the Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation N Engl J Med 327 1992 1406 1412
18. T.V. Glotezer, A.S. Hellkamp, J. Zimmeman Atrial high rate episodes detected by pace-maker diagnostics predict death and stroke Circulation 107 2003 1614 1619